Dean Rao

Hubei Key Laboratory Of Hepato Pancreato Biliary Diseases, State Key Laboratory For Diagnosis And Treatment Of Severe Zoonotic Infectious Diseases, Key Laboratory Of Organ Transplantation, Ministry Of Education And Ministry Of Public Health
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization.

From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization.

Journal: Cell communication and signaling : CCS

Published: May 14, 2025

ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation.

ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation.

Journal: Gut

Published: March 15, 2025

The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression.

The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression.

Journal: Cell death & disease

Published: February 10, 2025

MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation.

MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation.

Journal: Clinical and molecular hepatology

Published: December 24, 2024

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives.

Journal: Biomarker research

Published: June 11, 2024

GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway.

GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway.

Journal: Cell death & disease

Published: April 20, 2024

Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.

Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: March 26, 2024

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.

Journal: Experimental hematology & oncology

Published: January 28, 2024

Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker.

Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker.

Journal: Translational oncology

Published: September 13, 2023

LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis.

LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis.

Journal: Cellular signalling

Published: July 20, 2023

TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.

TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.

Journal: Journal of hepatocellular carcinoma

Published: April 20, 2023

Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR.

Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR.

Journal: Journal of cellular and molecular medicine

Published: December 01, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026